Press release
Colon Cancer Market Estimated to Experience a Hike in Growth by 2021
Get access to full summary @: http://www.persistencemarketresearch.com/market-research/colon-cancer-market.asp
Attributable epidemiological factors can be precancerous growth in the colon or genetic mutation. The American Society of Clinical Oncology (ASCO) recommends patients affected with colon cancer, for testing of genetic mutation in the KRAS gene which accounts for about 30% to 40% of colon tumors.
There are three primary recommended therapies for treating colon cancer – surgery, chemotherapy and radiation. Surgical procedures such as colonoscopy, endoscopic mucosal resection, colectomy and laparoscopy are preferred in early-stage and invasive colon cancer treatment therapy. Besides, chemotherapy involves administration of drugs that destroy cancer cells, usually recommended after the surgery to reduce the risk of recurrence.
A sample of this report is available upon request @ www.persistencemarketresearch.com/samples/5423
In addition, targeted drugs such as bevacizumab (Avastin), cetuximab (Erbitux), panitumumab (Vectibix) and regorafenib (Stivarga) are administered to patients with advanced colon cancer. Radiation therapy utilizes powerful X-ray radiations to kill the cancer cells left after surgery, shrink large tumors before the surgery or relieve symptoms of colon cancer. Usually combined with chemotherapy, radiation therapy aids in reducing the risk of recurrence.
According to the Colon Cancer Alliance, colon cancer is the third most commonly diagnosed and second leading cause of cancer in the U.S. Rising incidences of colon cancer and high pricing of products have attracted pharmaceutical companies to develop and market new products. Healthcare practitioners are now cautioned with the cost-benefit ratio of colon cancer drugs owing to large presence and high pricing of products in this market. Extensive research and development in this field is expected to provide better and more effective medications in the future.
To view TOC of this report is available upon request @ www.persistencemarketresearch.com/toc/5423
Some of the key players contributing to this market include Bedford Laboratories, Sanofi Aventis, Bayer AG, GlaxoSmithKline plc and Teva Pharmaceutical Industries Ltd.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Colon Cancer Market Estimated to Experience a Hike in Growth by 2021 here
News-ID: 619240 • Views: …
More Releases from Persistence Market Research
Europe Automotive Heat Exchanger Market to Reach US$ 8.9 Billion by 2031, Exhibi …
The Europe automotive heat exchanger market has been witnessing steady growth, driven by the rapid evolution of vehicle technologies, stricter emission norms, and the widespread adoption of electric and hybrid vehicles. According to Persistence Market Research, the market is valued at US$ 6.4 billion in 2024 and is projected to reach US$ 8.9 billion by 2031, expanding at a CAGR of 4.9% during the forecast period from 2024 to 2031.…
Digital Crosspoint Switches Market Anticipated to Hit USD 52.5 Billion by 2032
Overview of the Digital Crosspoint Switches Market
The global digital crosspoint switches market is expected to be valued at US$ 28.9 billion in 2025, with projections to reach US$ 52.5 billion by 2032, growing at a robust CAGR of 8.9% during the forecast period. This growth is fueled by the surging need for high-speed data transmission, the expansion of next-generation telecommunications networks, and the increasing deployment of data centers worldwide. As…
Multiformat Transcoders Market Estimated to Grow at 8.6% CAGR by 2032
Overview of the Multiformat Transcoders Market
The global multiformat transcoders market is poised for remarkable expansion, with an estimated valuation of US$ 1.3 billion in 2025, projected to reach US$ 2.3 billion by 2032. This growth trajectory represents a robust CAGR of 8.6% during the forecast period (2025-2032). The market's expansion is driven by the surging demand for high-quality video streaming, advancements in cloud-based transcoding technologies, and the rising consumption of…
Automotive Bearing and Clutch Component Aftermarket Set for 4.5% CAGR Growth, Su …
The global automotive bearing and clutch component aftermarket is poised for steady expansion over the forecast period. According to the latest findings from Persistence Market Research, the market is projected to grow from an estimated US$ 5.3 billion in 2024 to approximately US$ 7.2 billion by 2031, reflecting a compound annual growth rate (CAGR) of 4.5%. This market covers the replacement of bearings, clutch kits, and related clutch components that…
More Releases for Colon
Colon Broom Real Reviews - Does Colon Broom Work for Weight Loss?
Colon Broom is a regular fiber-based supplement that promotes healthy digestion and gut health by utilizing natural components. The product is aimed at people who are tired of slow digestion, bloating, and irregularity. However, rather than a harsh cleanse or a fast detox, this product takes a gentler, more sustainable approach: fiber.
The ingredients of Colon Broom are basic but effective, with psyllium husk being the star. …
Colon Cleansing Supplements Market Overview 2022 to 2030, Future Trends and Fore …
Colon Cleansing Supplements Market 2022 Global Industry research report provide detailed analysis of growth factors of the global industry as well as it gives analysis of market share, latest trends, size and forecast until 2030. The Colon Cleansing Supplements industry report has studied key opportunities in the market and influencing factor which is useful to the business.
The global Colon Cleansing Supplements market is expected to register a CAGR of 3.2%…
Global Colon Cleanse Market Analysis (2020-2025)
Global Info Research offers a latest published report on Colon Cleanse Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Colon Cleanse Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/266412/colon-cleanse
Market…
Global Colon Cleansing Supplements Market: Key Players to Tap Emerging Markets i …
LOS ANGELES, United States: QY Research as of late produced a research report titled, “Global Colon Cleansing Supplements Market Research Report 2020". The research report speak about the potential development openings that exist in the worldwide market. The report is broken down on the basis of research procedures procured from historical and forecast information. The global Colon Cleansing Supplements market is relied upon to develop generously and flourish as far…
Colon Cleansing Supplements Market- Key Vendors ( Vita Balance, PRIVATELABELSUPP …
Global Colon Cleansing Supplements Market: Snapshot
Colon cleansing is essential if one needs to lose a few pounds of weight, solve acne problems, or improve their digestive system. There are several supplements are now available that adequately match the requirements and according to the findings of this study, the demand for them would be expanding profitably over the course of 2017 to 2027, gaining traction from increased awareness levels among the…
Colon Cancer Pipeline Therapeutics Review H1 2017
Colon Cancer Pipeline Drugs Review H1 2017 provides an overview of the Colon Cancer therapeutics (Oncology) pipeline landscape. Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer.
For More on Colon Cancer Pipeline Review H1 2017 Report Inquire @ https://tinyurl.com/Colon-Cancer-Therapeutic .
Report Description:
Pharmaceutical guide Colon Cancer - Pipeline…
